Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPATIMUP is a leading Portuguese research and diagnostic institute specializing in molecular pathology and immunology, with a primary focus on oncology. Established in 1989 as a non-profit association of the University of Porto, it has become a reference center for cancer genetics and personalized medicine in Europe. The institute provides high-quality diagnostic services, including molecular profiling and genetic testing, to support clinical decision-making in cancer treatment. IPATIMUP is a founding member of the i3S (Instituto de Investigação e Inovação em Saúde), integrating its research efforts into a larger multidisciplinary health sciences framework. Its work spans basic research, translational medicine, and specialized training, significantly contributing to the understanding of cancer etiology and progression.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPATIMUP.